Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
Get Alerts COLL Hot Sheet
Join SI Premium – FREE
STOUGHTON, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the 22nd Annual Needham Healthcare Conference being held virtually from April 17-20, 2023.
Details of the event are as follows:Fireside Chat Date and Time: Tuesday, April 18, 2023, at 2:15 p.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:Christopher James, M.D.Vice President, Investor Relations[email protected]
Media Contact:Marissa SamuelsVice President, Corporate Communications[email protected]
Source: Collegium Pharmaceutical, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
- LOVE, DEATH & ROBOTS' Philip Gelatt and BRIGHTBURN's David Yarovesky Unleash IT DEMANDS SACRIFICE #1 with Legendary Artist Adam Pollina at BAD IDEA
- Virtual IOP For Teen OCD & Anxiety: Flexible Mental Health Program Expanded
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share